Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

89bio, Inc. - Common Stock (NQ:ETNB)

14.87 +0.02 (+0.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 89bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
89bio Stock Skyrockets After Roche’s $3.5B Buyout Offer: Retail Bullish, But A Wall Street Analyst Is Cautious
Via Stocktwits
Why Did 89bio Stock Nearly Double In Value Today?
Via Stocktwits
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, BERY, COMP, ETNB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume stocks are being observed in Tuesday's session.
On Tuesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’
BTIG said Pfizer’s $7.3 billion Metsera acquisition sharpens its clinical updates and strategic optionality. 
Via Stocktwits
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, ETNB, STAA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
In today's session, these stocks are experiencing unusual volume.
Let's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
From Kahn Swick & Foti, LLC
Via Business Wire
Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It
The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval. 
Via Benzinga
This United Parcel Service Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
 
Via Benzinga
Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback
Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since tariff-driven selloff. 
Via Benzinga
Topics ETFs Economy
Let's take a look at the stocks that are in motion in today's session.
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push
Roche is acquiring 89bio for $2.4 billion plus potential milestone payouts, bolstering its pipeline with late-stage MASH drug pegozafermin. 
Via Benzinga
Here are the top movers in Thursday's session.
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Gold Falls Over 1%; Darden Posts Downbeat Earnings
 
Via Benzinga
Traders are paying attention to the gapping stocks in Thursday's session.
In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Nasdaq Surges 100 Points; US Initial Jobless Claims Fall
 
Via Benzinga
Roche Digs Into Obesity-Tied Diseases With $3.5 Billion 89bio Buyout
The company is now focusing on MASH, a form of fatty liver disease common in people with obesity and type 2 diabetes. 
Via Investor's Business Daily
Discover the top movers in Thursday's pre-market session.
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Top 2 Health Care Stocks That May Keep You Up At Night This Month
 
Via Benzinga
ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Stock Market Today: S&P 500, Nasdaq, Dow Futures Jump Following Fed Rate Cut—Broadcom, Cracker Barrel, FedEx In Focus
U.S. stock futures advanced on Thursday following Wednesday's mixed moves. Futures of major benchmark indices were higher. 
Via Benzinga
Topics Economy Stocks
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Darden Restaurants, Factset Research And 3 Stocks To Watch Heading Into Thursday
U.S. stock futures trading higher, stocks to watch: Darden, Bullish, Factset. 89bio acquired by Roche. FedEx Q1 earnings expected. 
Via Benzinga
Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.